Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Superior Efficacy of Midostaurin Over Cladribine in Advanced Systemic Mastocytosis: A Registry-Based Analysis
Johannes Lübke, Juliana Schwaab, Nicole Naumann, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 16, pp. 1783-1794
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management
Animesh Pardanani
American Journal of Hematology (2023) Vol. 98, Iss. 7, pp. 1097-1116
Open Access | Times Cited: 60
The international consensus classification of eosinophilic disorders and systemic mastocytosis
Sa A. Wang, Attilio Orazi, Jason Gotlib, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 8, pp. 1286-1306
Closed Access | Times Cited: 28
Efficacy of avapritinib versus best available therapy in the treatment of advanced systemic mastocytosis
Andreas Reiter, Jason Gotlib, Iván Álvarez‐Twöse, et al.
Leukemia (2022) Vol. 36, Iss. 8, pp. 2108-2120
Open Access | Times Cited: 35
Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis
Andreas Reiter, Juliana Schwaab, Daniel J. DeAngelo, et al.
Blood Advances (2022) Vol. 6, Iss. 21, pp. 5750-5762
Open Access | Times Cited: 29
Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries
Johannes Lübke, Deborah Christen, Juliana Schwaab, et al.
Leukemia (2024) Vol. 38, Iss. 4, pp. 810-821
Open Access | Times Cited: 5
Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee
Donal P. McLornan, Tomasz Czerw, Gandhi Damaj, et al.
Leukemia (2024)
Closed Access | Times Cited: 5
Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group
Karl Sotlar, Tracy I. George, Philip M. Kluin, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 8, pp. 1986-1998.e2
Open Access | Times Cited: 20
Available and emerging therapies for bona fide advanced systemic mastocytosis and primary eosinophilic neoplasms
Jason Gotlib
Hematology (2022) Vol. 2022, Iss. 1, pp. 34-46
Open Access | Times Cited: 20
A clinical, morphological and molecular study of 70 patients with gastrointestinal involvement in systemic mastocytosis
Johannes Lübke, Nicole Naumann, Oliver Hoffmann, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Systemic Mastocytosis and Other Entities Involving Mast Cells: A Practical Review and Update
Siba El Hussein, Helen T. Chifotides, Joseph D. Khoury, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3474-3474
Open Access | Times Cited: 16
Proposed European Competence Network on Mastocytosis—American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis
Jason Gotlib, Juliana Schwaab, William Shomali, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 8, pp. 2025-2038.e1
Open Access | Times Cited: 15
Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis
Johannes Lübke, Nicole Naumann, Georgia Metzgeroth, et al.
Annals of Hematology (2023) Vol. 102, Iss. 8, pp. 2077-2085
Open Access | Times Cited: 8
KIT Mutations and Other Genetic Defects in Mastocytosis
Yannick Chantran, Peter Valent, Michel Arock
Immunology and Allergy Clinics of North America (2023) Vol. 43, Iss. 4, pp. 651-664
Open Access | Times Cited: 8
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM
Johannes Lübke, Alicia Schmid, Deborah Christen, et al.
Blood Advances (2024) Vol. 8, Iss. 11, pp. 2890-2900
Open Access | Times Cited: 2
Recent advances in diagnosis and therapy in systemic mastocytosis
Hyun Jung Lee
Blood Research (2023) Vol. 58, Iss. S1, pp. S96-S108
Open Access | Times Cited: 4
Unraveling the Rare Entity of KIT D816V-Negative Systemic Mastocytosis
Ruah Alyamany, Chams Alkhalaf Albachir, S. S. Al-Saleh, et al.
Journal of Hematology (2024) Vol. 13, Iss. 3, pp. 128-136
Open Access | Times Cited: 1
Target Therapies for Systemic Mastocytosis: An Update
Mariarita Sciumè, Claudio De Magistris, Nicole Galli, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 6, pp. 738-738
Open Access | Times Cited: 7
Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts
Peter Valent, Cem Akin, Michel Arock, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15125-15125
Open Access | Times Cited: 2
Advanced systemic mastocytosis—Revised classification, new drugs and how we treat
Animesh Pardanani, Kaaren K. Reichard, Ayalew Tefferi
British Journal of Haematology (2023) Vol. 204, Iss. 2, pp. 402-414
Closed Access | Times Cited: 2
Лечение агрессивного системного мастоцитоза и тучноклеточного лейкоза. Обзор литературы и серия клинических наблюдений
В. Г. Потапенко, З. К. Абдулхаликова, В В Байков, et al.
Clinical oncohematology (2024) Vol. 17, Iss. 2, pp. 180-194
Open Access
SOHO State of the Art Update and Next Questions: Current and Emerging Therapies for Systemic Mastocytosis
Helen T. Chifotides, Prithviraj Bose
Clinical Lymphoma Myeloma & Leukemia (2024)
Closed Access
Computational Modeling of Mast Cell Tryptase Family Informs Selective Inhibitor Development
Ying Ma, Bole Li, Xiangqin Zhao, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110739-110739
Open Access
Management of Advanced Systemic Mastocytosis: Clinical Challenges
Douglas Tremblay, Nicole Wagner, John O. Mascarenhas
Journal of Blood Medicine (2024) Vol. Volume 15, pp. 421-433
Open Access
Comparison of prognostic scores according to WHO classification in 170 patients with advanced mastocytosis and C‐finding treated with midostaurin
Maël Heiblig, C. Gourguechon, Philippe Guilpain, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 11, pp. 2127-2139
Open Access
Functional imaging with dual-energy computed tomography for supplementary non-invasive assessment of mast cell burden in systemic mastocytosis
Julia Riffel, Johannes Lübke, Nicole Naumann, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top